Clinical Outcomes in Musculoskeletal Involvement of Burkholderia Pseudomallei Infection.
10.4055/cios.2017.9.3.386
- Author:
Mohamad GOUSE
1
;
Viswanath JAYASANKAR
;
Shalom PATOLE
;
Balaji VEERARAGHAVAN
;
Manasseh NITHYANANTH
Author Information
1. Department of Orthopaedics, Christian Medical College and Hospital, Vellore, India.
- Publication Type:Original Article
- Keywords:
Burkholderia pseudomallei;
Synovitis;
Debridement;
Osteomyelitis
- MeSH:
Abscess;
Arthritis, Infectious;
Burkholderia pseudomallei*;
Burkholderia*;
Ceftazidime;
Debridement;
Diagnosis;
Doxycycline;
Follow-Up Studies;
Hospital Records;
Humans;
Melioidosis;
Musculoskeletal System;
Osteomyelitis;
Recurrence;
Synovitis;
Trimethoprim, Sulfamethoxazole Drug Combination
- From:Clinics in Orthopedic Surgery
2017;9(3):386-391
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Musculoskeletal involvement in melioidosis is often seen in conjunction with a disseminated illness. Recent reports suggest that operative management of musculoskeletal melioidosis has favourable results. The purpose of this study was to review the patient profile and clinical outcomes of Burkholderia pseudomallei infection in the musculoskeletal system. METHODS: Hospital records of 163 patients who were diagnosed to have B. pseudomallei infection between January 2009 and December 2014 were reviewed. Patients underwent surgical and nonsurgical management depending upon the tissue of involvement. Epidata software was used to record the data. The SPSS ver. 17.0 was used for analysis. RESULTS: Eighteen out of 24 patients who had musculoskeletal melioidosis were available for follow-up. Septic arthritis, osteomyelitis, and intramuscular abscess were the common diagnosis, with 6 patients in each group. Twelve patients required surgical intervention. All patients received a full course of parenteral ceftazidime followed by oral doxycycline and co-trimoxazole. Two out of 6 patients (33.3%) died among those who had nonsurgical management as compared to none in the group who had surgical management. This was significant at 10% level of significance (p = 0.098). The rest were followed up for a minimum of 1 year with no evidence of disease recurrence. CONCLUSIONS: This series describing musculoskeletal involvement in melioidosis is the largest such study from a recently recognized ‘endemic’ region. Of importance are the patterns of musculoskeletal involvement, pitfalls in diagnosis and adequate clinical response with timely diagnosis and appropriate surgical management.
